Interleukin enhancer-binding factor 3 (ILF3) (N-Term) anticorps
Aperçu rapide pour Interleukin enhancer-binding factor 3 (ILF3) (N-Term) anticorps (ABIN634215)
Antigène
Voir toutes Interleukin enhancer-binding factor 3 (ILF3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- ILF3 antibody was raised against the N terminal of ILF3
-
Purification
- Affinity purified
-
Immunogène
- ILF3 antibody was raised using the N terminal of ILF3 corresponding to a region with amino acids PTQEELEAVQNMVSHTERALKAVSDWIDEQEKGSSEQAESDNMDVPPEDD
-
-
-
-
Indications d'application
-
WB: 0.0625 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ILF3 Blocking Peptide, (ABIN5614181), is also available for use as a blocking control in assays to test for specificity of this ILF3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ILF3 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Autre désignation
- ILF3
-
Sujet
- ILF3 may facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. ILF3 can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. ILF3 can regulate protein arginine N-methyltransferase 1 activity.
-
Poids moléculaire
- 76 kDa (MW of target protein)
-
Pathways
- M Phase
Antigène
-